EPISODE · Sep 12, 2022 · 15 MIN
La lucha contra las bacterias resistentes
from Biotecnología Capital · host Capital Radio
El CEO de Abac Therapeutics, Domingo Gargallo-Viola, explica el acuerdo alcanzado con dos empresas para desarrollar antibióticos que puedan luchar contra las bacterias resistentes a los antibióticos.
Embed this episode
NOW PLAYING
La lucha contra las bacterias resistentes
0:00
15:56
1×
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Biotecnología Capital?
This episode is 15 minutes long.
When was this Biotecnología Capital episode published?
This episode was published on September 12, 2022.
Can I download this Biotecnología Capital episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!